The Rosen Law Firm, a global investor rights firm, reminds purchasers of Insulet Corporation (NASDAQ:PODD) securities from February 27, 2013 through April 30, 2015 (the “Class Period”) of the important July 6, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Insulet investors under the federal securities laws.
To join the Insulet class action, go to the firm’s website at http://www.rosenlegal.com/cases-608.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The lawsuit alleges that during the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Insulet was experiencing slower demand for its products; (2) Insulet was facing issues with its sales and marketing efforts; (3) consequently, Insulet experienced unevenness in its financial performance; and (4) as a result, defendants’ positive statements about the Insulet’s business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 6, 2015. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-608.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at email@example.com or firstname.lastname@example.org.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.